Helena Santos
Chief Executive Officer bij SCIENTIFIC INDUSTRIES, INC.
Vermogen: 458 461 $ op 31-03-2024
Profiel
Helena R.
Santos currently works at Scientific Industries, Inc., as President, Chief Executive Officer & Director from 2024 and Altamira Instruments, Inc., as President & Treasurer.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-01-2024 | 258 288 ( 3.69% ) | 458 461 $ | 31-03-2024 |
Actieve functies van Helena Santos
| Bedrijven | Functie | Begin |
|---|---|---|
| SCIENTIFIC INDUSTRIES, INC. | Chief Executive Officer | 01-08-2002 |
Altamira Instruments, Inc.
 Altamira Instruments, Inc. Medical SpecialtiesHealth Technology Altamira Instruments, Inc. manufactures catalyst characterization instrumentation and bench-scale micro-reactor systems for industrial and research use. Its products and services include: single and multi-station characterization systems from the AMI family; bench-scale, rack-mounted, catalytic micro-reactor systems from the BenchCAT line; pulse chemisorption; catalysis consulting and technical assistance to clients; high throughput reactor systems for catalyst screening from the BenchCAT-HTS family and Benchtop micro-reactor systems from the BenchCAT line. The company was founded in 1984 and is headquartered in Pittsburgh, PA. | President | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SCIENTIFIC INDUSTRIES, INC. | Producer Manufacturing |
| Bedrijven in privébezit | 1 |
|---|---|
Altamira Instruments, Inc.
Altamira Instruments, Inc. Medical SpecialtiesHealth Technology Altamira Instruments, Inc. manufactures catalyst characterization instrumentation and bench-scale micro-reactor systems for industrial and research use. Its products and services include: single and multi-station characterization systems from the AMI family; bench-scale, rack-mounted, catalytic micro-reactor systems from the BenchCAT line; pulse chemisorption; catalysis consulting and technical assistance to clients; high throughput reactor systems for catalyst screening from the BenchCAT-HTS family and Benchtop micro-reactor systems from the BenchCAT line. The company was founded in 1984 and is headquartered in Pittsburgh, PA. | Health Technology |
